Download
s00228-020-03041-5.pdf 719,95KB
WeightNameValue
1000 Titel
  • Serum 4β-hydroxycholesterol increases during fluconazole treatment
1000 Autor/in
  1. Lütjohann, Dieter |
  2. Stellaard, Frans |
  3. Kerksiek, Anja |
  4. Lötsch, Jörn |
  5. Oertel, Bruno G |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-11-17
1000 Erschienen in
1000 Quellenangabe
  • 77(5):659-669
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00228-020-03041-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032583/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!The antifungal drugs ketoconazole and itraconazole reduce serum concentrations of 4β-hydroxycholesterol, which is a validated marker for hepatic cytochrome P450 (CYP) 3A4 activity. We tested the effect of another antifungal triazole agent, fluconazole, on serum concentrations of different sterols and oxysterols within the cholesterol metabolism to see if this inhibitory reaction is a general side effect of azole antifungal agents.!##!Methods!#!In a prospective, double-blind, placebo-controlled, two-way crossover design, we studied 17 healthy subjects (nine men, eight women) who received 400 mg fluconazole or placebo daily for 8 days. On day 1 before treatment and on day 8 after the last dose, fasting blood samples were collected. Serum cholesterol precursors and oxysterols were measured by gas chromatography-mass spectrometry-selected ion monitoring and expressed as the ratio to cholesterol (R_sterol).!##!Results!#!Under fluconazole treatment, serum R_lanosterol and R_24,25-dihydrolanosterol increased significantly without affecting serum cholesterol or metabolic downstream markers of hepatic cholesterol synthesis. Serum R_4β-, R_24S-, and R_27-hydroxycholesterol increased significantly.!##!Conclusion!#!Fluconazole inhibits the 14α-demethylation of lanosterol and 24,25-dihydrolanosterol, regulated by CYP51A1, without reduction of total cholesterol synthesis. The increased serum level of R_4β-hydroxycholesterol under fluconazole treatment is in contrast to the reductions observed under ketoconazole and itraconazole treatments. The question, whether this increase is caused by induction of CYP3A4 or by inhibition of the catabolism of 4β-hydroxycholesterol, must be answered by mechanistic in vitro and in vivo studies comparing effects of various azole antifungal agents on hepatic CYP3A4 activity.
1000 Sacherschließung
lokal Double-Blind Method [MeSH]
lokal Age Factors [MeSH]
lokal Lanosterol/analogs
lokal Antifungal Agents/pharmacology [MeSH]
lokal Bile acid precursors
lokal Cytochrome P450
lokal Lipid Metabolism [MeSH]
lokal Sterols/metabolism [MeSH]
lokal Oxysterols
lokal Male [MeSH]
lokal Sex Factors [MeSH]
lokal Cholesterol synthesis
lokal Cytochrome P-450 CYP3A/metabolism [MeSH]
lokal Female [MeSH]
lokal Hydroxycholesterols/blood [MeSH]
lokal Fluconazole/pharmacology [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Clinical Trial
lokal Antifungal
lokal Cholesterol metabolism
lokal Cross-Over Studies [MeSH]
lokal Bile Acids and Salts/metabolism [MeSH]
lokal Young Adult [MeSH]
lokal Lanosterol/metabolism [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-7941-8308|https://orcid.org/0000-0002-0362-7330|https://frl.publisso.de/adhoc/uri/S2Vya3NpZWssIEFuamE=|https://frl.publisso.de/adhoc/uri/TMO2dHNjaCwgSsO2cm4=|https://frl.publisso.de/adhoc/uri/T2VydGVsLCBCcnVubyBH
1000 Hinweis
  • DeepGreen-ID: 334e6cd342b34d4ba93ed1bd0f30ada8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Serum 4β-hydroxycholesterol increases during fluconazole treatment
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470198.rdf
1000 Erstellt am 2023-11-18T04:34:29.570+0100
1000 Erstellt von 322
1000 beschreibt frl:6470198
1000 Zuletzt bearbeitet Fri Dec 01 11:19:40 CET 2023
1000 Objekt bearb. Fri Dec 01 11:19:40 CET 2023
1000 Vgl. frl:6470198
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470198 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source